Strs Ohio Cullinan Oncology, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$15.63 - $29.35 $34,386 - $64,570	2,200 Added 6.9%	34,100 $594,000
Q1 2024 May 13, 2024	BUY	$10.17 - $19.02 $324,423 - $606,738	31,900 New	31,900 $543,000
Q4 2021 Jan 24, 2022	SELL	$15.36 - $25.0 $56,832 - $92,500	-3,700 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$22.56 - $29.68 $11,280 - $14,840	500 Added 15.63%	3,700 $83,000
Q1 2021 Apr 23, 2021	BUY	$28.0 - $53.42 $89,600 - $170,944	3,200 New	3,200 $133,000

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.